forty four Additionally, anergic cells Commonly keep the next susceptibility to apoptosis Until anti-apoptotic proteins including BCL2 are overexpressed, as is the case for CLL cells.forty five In fact, most key therapeutic improvements taking place in the last 10 years are connected to the inhibition of BCR and BCL2-mediated signaling.Incredibly j